Follow-The-Filings

Security · featured owners

MRVI Maravai Lifesciences Hldgs I

COM CL A Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.1%
  • $28M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (First Pacific Advisors) · not free-float ownership

  1. First Pacific Advisors 0.07%
  2. First Eagle Investment Manage... add 0.04%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
First Eagle Investment Management 2026 Q2 0.04% Add +45.4% 3,671,287 $23M history
First Pacific Advisors 2026 Q2 0.07% Hold 884,883 $6M history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $288.94M $259.18M $185.74M
Gross profit * $140.2M $108.31M $33.99M
Gross margin * 48.5% 41.8% 18.3%
Net income -$119.03M -$144.85M -$130.77M
Net margin * -41.2% -55.9% -70.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $699.91M $681.5M $296.25M
Total non-current assets * $787.54M $762.25M $474.33M
Total assets $1.49B $1.44B $770.58M
Total current liabilities $87.47M $68.62M $44.92M
Total non-current liabilities * $610.1M $602.64M $352.95M
Total equity $416.75M $434.73M $212.38M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $126.22M $7.46M -$57.57M
Cash from investing -$122.31M -$24.32M -$31.4M
Cash from financing -$61.09M -$235.71M -$16.5M
Net change in cash -$57.18M -$252.56M -$105.51M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders